%PDF-1.3
%
60 0 obj
<>/OCGs[64 0 R]>>/Pages 48 0 R/Type/Catalog>>
endobj
62 0 obj
<>/Font<>>>/Fields 68 0 R>>
endobj
63 0 obj
<>stream
application/pdf
nhough
R0892G
R0892G
1999-05-05T14:24:48
Adobe PageMaker 6.52
2014-07-11T10:46:16+01:00
2014-07-11T10:46:16+01:00
Acrobat Distiller 3.0 for Windows
uuid:b893c87d-004e-40bd-88a5-92c813b31a49
uuid:0b7a5e29-5e62-4801-880d-29985e8d1baa
endstream
endobj
48 0 obj
<>
endobj
15 0 obj
<>
endobj
49 0 obj
<>
endobj
45 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Type/Page>>
endobj
51 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Type/Page>>
endobj
74 0 obj
<>stream
q
1 0 0 1 5.743301 1.564224 cm
0 0 595 842 re
W n
1 0 0 1 -5.743301 -1.564224 cm
BT
0 0 0 rg
/GS0 gs
/T1_0 1 Tf
0.037 Tc 10 0 0 10 53.9633 33.3542 Tm
(R96)Tj
0.022 Tc -0.01 Tw 18.144 76.848 Td
(Communicable Disease Report)Tj
0.001 Tc -0.045 Tw 8.5 0 0 8.5 58.1633 801.2342 Tm
(Vol 2 Review No 8)Tj
0.026 Tc -0.07 Tw 52.405 0.056 Td
(17 July 1992)Tj
-0.001 Tc 0.035 Tw 18 0 0 18 45.4433 757.6742 Tm
[(\221CO)52(VER\222)79( \(Co)12(v)32(er of v)26(accination e)26(v)26(aluated r)12(apidly\):)52( 22)]TJ
/T1_1 1 Tf
0.014 Tc -0.049 Tw 9.5 0 0 9.5 45.5633 723.4742 Tm
(The COVER programme, a scheme for the rapid evaluation)Tj
0.033 Tc 0.253 Tw 0 -1.213 TD
(of vaccine coverage, started in January 1987 with 14)Tj
0.017 Tc 0.252 Tw 0 -1.2 TD
(districts contributing data \()Tj
/T1_2 1 Tf
13.288 0 Td
(Communicable Disease Report)Tj
/T1_1 1 Tf
0.031 Tc 0.253 Tw -13.288 -1.213 Td
(1987; \(12\): 3-6\). This twenty-second quarterly report)Tj
0.014 Tc -0.082 Tw 0 -1.213 TD
(includes information from 185 districts.)Tj
/T1_3 1 Tf
-0.009 Tc 12 0 0 12 45.5633 650.3942 Tm
(Methods)Tj
/T1_1 1 Tf
0.009 Tc 0.253 Tw 9.5 0 0 9.5 45.5633 638.7542 Tm
(The data were collected at the beginning of May 1992.)Tj
-0.006 Tc -0.009 Tw T*
(Vaccination data were requested for quarterly cohorts whose)Tj
-0.03 Tw T*
(youngest member had reached the target ages for completion)Tj
0.055 Tw 0 -1.2 TD
(of immunisation: 18 months for the third dose of diphtheria)Tj
-0.008 Tc -0.111 Tw 0 -1.213 TD
(\(D3\) and pertussis \(P3\) vaccines and 24 months for measles. For)Tj
-0.006 Tc 0.158 Tw T*
(D3 and P3, data were also requested for quarterly cohorts)Tj
-0.046 Tw T*
(whose youngest member had reached a lower target age of 12)Tj
0.1 Tw T*
(months. The cohorts studied were those born in January to)Tj
0.015 Tw T*
(March 1991 \(for D3 and P3 by 12 months\), July to September)Tj
-0.041 Tw 0 -1.2 TD
(1990 \(for D3 and P3 by 18 months\) and January to March 1990)Tj
-0.01 Tc -0.111 Tw 0 -1.213 TD
(\(for measles by 24 months\).)Tj
/T1_3 1 Tf
-0.014 Tc 12 0 0 12 45.5633 493.7942 Tm
(Results)Tj
/T1_1 1 Tf
0.031 Tc 0.252 Tw 9.5 0 0 9.5 45.5633 482.1542 Tm
(Altogether, 185 districts participated from 14 English)Tj
0.026 Tc -0.059 Tw T*
(regions, Wales and Northern Ireland. Data were available)Tj
0.027 Tc 0.202 Tw T*
(for every district in seven English regions, Wales and)Tj
0.078 Tw 0 -1.2 TD
(Northern Ireland. In all other regions \(except Trent and)Tj
0.026 Tc -0.058 Tw 0 -1.213 TD
(Mersey\) at least 80% of districts participated. The average)Tj
0.027 Tc 0.088 Tw T*
(cover* by 12 months was )Tj
/T1_3 1 Tf
0.028 Tc 12.354 0 Td
(93%)Tj
/T1_1 1 Tf
0.026 Tc 1.971 0 Td
( for D3 \(district range 75-)Tj
0.027 Tc -0.005 Tw -14.324 -1.213 Td
(98%\) and )Tj
/T1_3 1 Tf
0.028 Tc 4.585 0 Td
(89%)Tj
/T1_1 1 Tf
0.027 Tc -0.007 Tw 1.971 0 Td
( for P3 \(district range 70-97%\). Cover by 18)Tj
0.034 Tw -6.556 -1.213 Td
(months was )Tj
/T1_3 1 Tf
0.028 Tc 5.962 0 Td
(94%)Tj
/T1_1 1 Tf
0.027 Tc 0.036 Tw 1.971 0 Td
( for D3 \(district range 70-99%\) and )Tj
/T1_3 1 Tf
0.028 Tc 16.661 0 Td
(90%)Tj
/T1_1 1 Tf
0.027 Tc -0.024 Tw -24.594 -1.213 Td
(for P3 \(district range 68-96%\). For measles, average cover)Tj
0.021 Tw 0 -1.2 TD
(by 24 months was )Tj
/T1_3 1 Tf
0.028 Tc 8.754 0 Td
(92%)Tj
/T1_1 1 Tf
0.026 Tc 1.971 0 Td
( \(district range 65-99%\).)Tj
/T1_3 1 Tf
0 Tc 12 0 0 12 45.5633 355.4342 Tm
(Comment)Tj
/T1_1 1 Tf
0.027 Tc 0 Tw 9.5 0 0 9.5 45.5633 343.9142 Tm
(We report COVER data from 185 of 198 \(93%\) districts in)Tj
0.026 Tc 0.048 Tw 0 -1.213 TD
(England, Wales and Northern Ireland. Vaccine coverage)Tj
0.027 Tc 0.034 Tw T*
(has improved by 1% for both D3 \(12 months\) and P3 \(18)Tj
0.047 Tw T*
(months\) since the previous report. Measles coverage \(24)Tj
-0.042 Tw T*
(months\) has also improved by 1%. For the first time, 90%)Tj
0.147 Tw T*
(coverage has been achieved nationally for all antigens.)Tj
-0.039 Tw 0 -1.2 TD
(The new target of 95% coverage has been achieved by 120)Tj
-0.072 Tw 0 -1.213 TD
(districts for D3 at 18 months \(Figure 1a\), 20 districts for P3)Tj
-0.031 Tw T*
(at 18 months \(Figure 1b\) and 65 districts for measles at 24)Tj
0.029 Tc 0.253 Tw T*
(months \(Figure 1c\). Seven English regions \(Northern,)Tj
0.027 Tc -0.04 Tw T*
(Yorkshire, Trent, East Anglia, Wessex, Oxford and South)Tj
0.026 Tc 0.186 Tw T*
(Western\) and Northern Ireland have average coverage)Tj
0.027 Tc -0.085 Tw 0 -1.2 TD
(levels of 90% or more for all the antigens evaluated and, in)Tj
0.043 Tc 0.253 Tw 0 -1.213 TD
(one of these regions \(South Western\), every district)Tj
0.027 Tc -0.045 Tw T*
(achieved 90% or more for all antigens. At the other end of)Tj
0.026 Tc -0.07 Tw T*
(the spectrum, coverage was below 80% in two districts for)Tj
0.027 Tc -0.032 Tw T*
(D3 at 18 months, five districts for P3 at 18 months and six)Tj
0.025 Tw T*
(districts for measles at 24 months.)Tj
/T1_2 1 Tf
0.026 Tc 0.012 Tw 0 -3.032 TD
(J M White BSc)Tj
0.028 Tc 0.026 Tw 0 -1.225 TD
(S Leon)Tj
0.027 Tc 0.073 Tw 0 -1.213 TD
(Immunisation Division)Tj
0.069 Tw 0 -1.225 TD
(PHLS Communicable Disease Surveillance Centre)Tj
/T1_0 1 Tf
0.026 Tc 0.022 Tw 8 0 0 8 45.4433 52.5542 Tm
(* The regional breakdown of these data is available on request)Tj
/T1_3 1 Tf
0 Tc 0.072 Tw 9 0 0 9 314.7233 723.7142 Tm
[(Figure )10(1)-653(Districts that have achieved 95% vaccine coverage)]TJ
-0.001 Tc 0.042 Tw 4.413 -1.267 Td
(by May 1992)Tj
0 Tc 0.067 Tw -4.4 -1.6 Td
[(a)-20(\))-707(Diphtheria \(D3\) at 18 months)]TJ
ET
q
1 0 0 1 45.443301 76.914224 cm
0 0 0 RG
0.48 w
/GS1 gs
0 0 m
252.24 0 l
S
Q
q
/GS1 gs
0 0 0 rg
245.9 0 0 633.25 314.743301 55.914224 cm
/Im0 Do
Q
q
1 0 0 1 5.743301 1.564224 cm
1 g
/GS1 gs
302.75 272.05 120.5 -17 re
f*
Q
q
1 0 0 1 5.743301 1.564224 cm
1 g
/GS1 gs
302.15 493.4 140.95 -17 re
f*
Q
BT
/GS2 gs
/T1_3 1 Tf
0.06 Tw 9 0 0 9 314.7233 482.7542 Tm
[(b)-16(\))-613(Pertussis \(P3\) at 18 months)]TJ
0.061 Tw 0 -24.4 TD
[(c)-23(\))-773(Measles at 24 months)]TJ
ET
/Artifact <>BDC
Q
q
1 0 0 1 528.8635254 837.6002197 cm
/GS3 gs
/Fm0 Do
Q
EMC
endstream
endobj
78 0 obj
<>>>/Resources<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
q
BT
0 g
0 i
/C2_0 10 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 0 -7.896 TD
<002F002C0037001100130013001400110017001B00130013>Tj
ET
Q
endstream
endobj
50 0 obj
<>/Filter/CCITTFaxDecode/Height 3518/ImageMask true/Length 20331/Name/Im1/Subtype/Image/Type/XObject/Width 1366>>stream
,P̭w_]ts TK";3DMxF2`t:䛩d*;ِBZ_̫Hw'(O ӿP_L&PAo̰5=o+P i렸^pOZ]y d/*.Mg\/W_¨/wA
?x^mz
BA]}O^U֟U_>uui =zx_z]An2;'-ˆ@h/%c$H1~<r {O }}Q?|7}7AUj+ᯯ`r
u_p]kiwKOHP,?}e%!
Zz 2ClC$5
~fnX"kL
}ߐ
0;2C,
2AqI ?O4~7ށK__z@aޙOOd9,5!63FlOxOp1Ou@" ~ *
^U_=i]鷥w 0jgUֽ4ân
"
Rz!n/L@?ûA ^M>Ӱ(XA0i Tԏ_&푰@ 6J
v5WmpCXqؠC.߲d
!
|C*5MWaP(;!M:Ope%%a xΦ ozj0V\=pЬdKA_A? x4z
i~>?v};'«zQ~A=_iO@h?߿ aCa|2}|C+rzR[ ;{dtŐh!*@ăAAw}i`0d
/S>iCcuȩ2XdLxa@(?E?[~"l!sNmw!
;P@AwU?w!vW"=wȰA# dND#T':!Ié>"F~OUk@
_ `WSu?_4]L<VZw_au^1_v+U&8_4= TDrC0W д"Іae!+=["
Xo,2;{#ArXe 6 Ö9t'-E"#qokt@lx}a!bA=Yt8OL=q\F0VC!p("Dr- d ru
PNdߝ0fQ!Gw=Y ,B
MV`x,7a;0[o|7]^ ٥
i<6!IA?݄4삉'AW"d
kma"ݩགl3'CY@Y`@?_d6) 4Kwaa+m};a 76C?p[ b{tu!#Zøa5LT;C3@]S:AW`Åzu
~ڷІ
ٍ;[¯aPXʘ1j0H0`(+8/*
A4$?
Ak r
w @o֫ n8&oAa3x2'(F`xm^iv?PA0Lx~eWR@`?
dd$h0_C߸[}ե_I/ kpՄ^otCLu!*;A+7)aI ]?Hk؈4j T v0DXp;K<*
/j9=WOW%nDl3(A0L h>?nC - dECUO&U<#B$0@߾ 8)KJpK٪" 0$x0BPKl Hi_AqT=BlW
C
%I>
xkA/
SC0H.y]$AHVl@< jm
.y
j
1`lI{C$2C$
IOZ.ZPv/bAZ [2NJZY
D_BUASH)-;P^"X`xIB@UH།>X?I"y,0_W_~~ ?_VM
-oAm
b
}P{w
~([o(p\h_4m<>Q.w ca6T7|1 -u? ՆAֿ`O*0ajߦ{~{bg^{YU
>;
a' a?-wC$m8/B~/2Vn ۿ[צd2CK/%ѬS'egBl1 dh@@0AM=AiP[0*vߌ,/Ǿ_ +0 ^Ga;r8؋#8\P@;`}wvA
֘Aguewau #^=#!7mP--մۆTl
n/l2n`okl%!®̆@pA;"H pKrgdX<4'dZ#pIЊ9(rxR(+5YF3U}H5$H5N,`mpDC0[,@f$7RaX}B[?[j~glC
A0[8j,@CvLIFl, Pj =t~KH@`_DaEha5\`}Yq̾HdYjvjoܔAف <20m`(H+&-[q`lj%Y